NCT06952803 2026-04-21
EvoPAR-PR02
AstraZeneca
Phase 3 Recruiting
Clinical Trials
8 trialsNCT06890884 2026-04-20
MK-2140-011
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT06925737 2026-04-20
MK-2400-001
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT04884035 2026-04-17
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Celgene
Phase 1 Recruiting
NCT05888493 2026-04-17
LEDA
Novartis
Phase 3 Active not recruiting
NCT06717347 2026-04-16
MK-2140-010
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT07221838 2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Recruiting
NCT07005154 2026-04-02
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Astellas Pharma Inc
Phase 2 Recruiting